Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23% for ...
Southfield-based PharmaCo Inc. — a cannabis company linked to a bribery scheme to Michigan’s then-top marijuana regulator ...
United States Steel Corp. is losing one of the members of its board of directors. Jeh C. Johnson, U.S. Homeland Security ...
Johnson & Johnson shares are down 3% Wednesday on safety concerns that could dim sales prospects for a new heart device, ...
Dwayne Johnson now holds a greater stake in WWE, the place where his journey began. As AFROTECHâ„¢ previously reported, the ...
The Netflix documentary ‘Don’t Die’ follows a tech millionaire’s quest to live forever. Here’s everything to know about Bryan ...
JNJ has an attractive 3.41% dividend yield comparable to the yield on long-term bonds. Given the lack of price movement and ...
Wells Fargo analyst Larry Biegelsen maintained a Hold rating on Johnson & Johnson (JNJ – Research Report) yesterday and set a price target ...
The Man Who Wants to Live Forever introduced many viewers to the Minicircle company, and here's what the organization ...
Johnson & Johnson closed $22.62 below its 52-week high ($168.85), which the company achieved on September 4th.
Johnson & Johnson closed $25.19 below its 52-week high ($168.85), which the company reached on September 4th.
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...